Digital Maintenance Asthma Inhaler Therapy Gets FDA Approval
The FDA has approved the AirDuo Digihaler for the treatment of asthma in patients aged 12 years and older.
Asthma
Nasal Airway Microbiota Linked to Asthma Exacerbation Risk in Children
Children with asthma who had nasal airway microbiota populations dominated by Moraxella had increased exacerbation risk and eosinophil activation, according to the results of a study published in the Journal of Allergy and Clinical Immunology. Nasal secretion samples were collected during the fall season from children aged 6 to 17 years with asthma who were…
Dupilumab Improves Symptoms in Uncontrolled Asthma
Patients with uncontrolled asthma who were treated with dupilumab experienced significant improvements in functional symptoms and risk profiles compared with placebo.
Mepolizumab Eligibility More Likely in Adults vs Kids With Severe Asthma
Children with severe asthma were less likely to be eligible for mepolizumab than adults with severe asthma.
IgE Reactivity to Cockroach Varies in Children With Asthma and Rhinitis
Immunoglobulin E reactivity varies significantly in children with asthma and rhinitis in allergic reactions to cockroaches.
Asthma Exacerbations May Be Linked to Elevated Levels of Air Pollution
Winter and summer elevations of ozone, sulfur dioxide, and nitrogen dioxide may be associated with moderate to severe asthma exacerbations in nonsmoking adults.
The Asthma-Mental Health Connection: Expert Clinicians Weigh In
Patients with asthma have demonstrated an elevated risk for depression and anxiety that is potentially twice as high as that in the general population.
Cellular Differences in Asthma Identified in First Lung Mapping Project
For the first time, the interactions of lung-resident structural and inflammatory cells have been profiled in both healthy individuals and those with asthma.
Self-Management Asthma Interventions Improve QoL in Older Adults
Older adults with asthma treated with a self-management, customized support intervention had improved quality of life and better control of their asthma.
Estimated Economic, Health Burden of Uncontrolled Asthma in the United States
The total economic burden of uncontrolled asthma in the United States during the next 20 years is estimated to be $963.5 billion.
Next post in Asthma
